Skip to main content
Contact Us
Subscriber Sign In
navigation
サイト内検索
What We Do
Commercial Intelligence
Products
Evaluate Pharma
Evaluate Omnium
Evaluate Medtech
Evaluate Epi
Japan Drug Forecasts
Europe Drug Forecasts
CDMO Intelligence
Pharma Consulting & Analytics
Pharma Consulting & Analytics
Data Feeds
Evaluate Vantage
News
Analysis
Policy & Pricing
Insights
Events
Medtech
Therapy Areas
Evaluate for Biotech
How We Can Help You
Pharma and Biotech
Financial Services
Management Consultancies
Service Providers
Customer Testimonials
Thought Leadership
Multimedia
Blog
About Us
Press Releases
Media Coverage
Executive Team
Vision & History
Contact Us
Sign Up for Evaluate Vantage
Talent
Subscriber Sign In
Search
Open configuration options
Search
Vantage
News
Snippets
Deals
Trial results
Patents and litigation
Corporate strategy
Analysis
Interviews
Spotlight
Vantage points
Vantage views
Insights
M&A
IPO
NME approvals
Quarterly shareprice performance
Venture financing
Vantage data points
Other data
Events
Company events
Conferences
Upcoming events
Medtech
Therapy Areas
Breadcrumb
Home
Vantage
Pharmaceutical Companies
Guidant
Evaluate
May 06, 2016
Debt, integration and buyer’s remorse: can Abbott pull off its deals?
September 03, 2015
Interview – Boston’s long road to recovery
July 07, 2015
Big-cap medtech shares fall as atmosphere cools
April 29, 2015
Boston opts to fill the gaps through licencing
March 02, 2015
Endo exits medtech – almost
June 16, 2014
Medtronic keeps up the heat in medtech with $43bn bid for Covidien
April 24, 2014
Zimmer and Biomet hook up for second orthopaedics megamerger
January 27, 2014
Medtech M&A picks up in the second half but still disappoints
August 13, 2013
Medtech employment buoyant in 2012 despite tax fears
October 29, 2012
2012 sees largest pure medtech buy for seven years, but value of deals slump 27%
August 27, 2008
Pfizer remains likely candidate to strike mega-merger
Load More
Latest Reports
July 27, 2023
H1 Round Up: The haves and the have-nots
July 21, 2023
ADA/EASL eBook
Editor's Picks
July 03, 2023
Astrazeneca and Daiichi’s big reveal disappoints
July 13, 2023
Pharma finds a way to gain weight
July 03, 2023
Protagonist investors flake as psoriasis pill disappoints
June 29, 2023
Approaching datasets for big pharma
June 27, 2023
Nkarta goes back to basics